---
schema_version: "secwatch.filing_event.v1"
accession: "0000917520-24-000105"
form_type: "8-K"
ticker: "IART"
cik: "0000917520"
company_name: "INTEGRA LIFESCIENCES HOLDINGS CORP"
filed_at: "2024-11-04T23:59:59+00:00"
generated_at: "2026-05-30T06:44:36.219568+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Integra LifeSciences names Mojdeh Poul as President & CEO effective Jan 6, 2025

## Summary
- Mojdeh Poul appointed President & CEO, effective January 6, 2025, succeeding Jan De Witte.
- Poul previously EVP & Group President of 3M's $8.5B global healthcare business.
- Poul to receive base salary of $1.05M, target bonus 125%, and initial equity awards totaling $6.75M.
- Jan De Witte's resignation is part of a previously announced succession plan; no disagreement.
- Stuart Essig to remain Executive Chairman temporarily before returning to non-executive role.

## SEC filing metadata
- accession: 0000917520-24-000105
- form_type: 8-K
- ticker: IART
- cik: 0000917520
- company_name: INTEGRA LIFESCIENCES HOLDINGS CORP
- filed_at: 2024-11-04T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/917520/000091752024000105/0000917520-24-000105-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/917520/000091752024000105/iart-20241104.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000917520-24-000105
- JSON: https://secwatch.observer/filing/0000917520-24-000105.json
- Plain text: https://secwatch.observer/filing/0000917520-24-000105.txt

## Key facts
- Executive change
  Mojdeh Poul was appointed as President and Chief Executive Officer at INTEGRA LIFESCIENCES HOLDINGS CORP.
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: On November 4, 2024, Integra LifeSciences Holdings Corporation (the “Company”) announced the appointment of Mojdeh Poul to serve as its President and Chief Executive Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/917520/000091752024000105/0000917520-24-000105-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.